Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
Trial Information
An Open Pilot Study of Varenicline (Chantix) in Adult Smokers with Attention Deficit Hyperactivity Disorder (ADHD): Effects on ADHD and Cigarette Smoking
Do you have problems concentrating, sitting still, or paying attention? Do you smoke cigarettes and want to stop? If so, you may be eligible to participate in an 8-week research study for adults ages 18-60 conducted by the Psychopharmacology Unit at Massachusetts General Hospital.
This study is designed to examine whether a medication approved by the FDA to quit smoking will help individuals with Attention Deficit Hyperactivity Disorder (ADHD). In order to be eligible for this study, you must not be taking any other drug therapy for your ADHD during this study. The study clinician will tell you how and when to stop safely.
Participants will receive an evaluation, assessments and follow-up visits at no cost. Participants will be responsible for the cost of study medication, which costs about the same as buying a pack of cigarettes a day.
Kerry Brodziak
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-724-ADHD
EMail: PPPCresearch@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
